Ratings by H.C. Wainwright (Vernon Bernardino)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/27/2026 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2026 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (N/A) |
|
Details | ||
| 1/21/2026 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (Buy) |
|
Details | ||
| 11/20/2025 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (Buy) |
|
Details | ||
| 10/16/2025 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2025 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (Buy) |
|
Details | ||
| 4/14/2025 | Citius Pharmaceuticals | CTXR | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2025 | Candel Therapeutics Inc. | CADL | Maintain | Buy (Buy) |
|
Details | ||
| 4/8/2025 | Phio Pharma | PHIO | Maintain | Buy (Buy) |
|
Details | ||
| 4/8/2025 | Cardiol Therapeutics | CRDL | Maintain | Buy (Buy) |
|
Details | ||
| 3/26/2025 | Cassava Sciences | SAVA | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/25/2025 | Moleculin Biotech | MBRX | Maintain | Buy (Buy) |
|
Details | ||
| 3/20/2025 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2025 | Candel Therapeutics Inc. | CADL | Maintain | Buy (Buy) |
|
Details | ||
| 3/13/2025 | Edesa Biotech Inc. | EDSA | Maintain | Buy (Buy) |
|
Details | ||
| 3/5/2025 | Cassava Sciences | SAVA | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/5/2025 | Senseonics Holdings | SENS | Maintain | Buy (Buy) |
|
Details | ||
| 3/3/2025 | Moleculin Biotech | MBRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2025 | Phio Pharma | PHIO | Maintain | Buy (Buy) |
|
Details | ||
| 12/18/2024 | Candel Therapeutics Inc. | CADL | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2024 | Novavax | NVAX | Maintain | Buy (Buy) |
|
Details | ||
| 11/26/2024 | Cassava Sciences | SAVA | Downgrade | Neutral (Buy) |
4.30 (2.38) |
-44.65% | Details | |
| 11/25/2024 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (Buy) |
|
Details | ||
| 11/20/2024 | Eledon Pharamceuticals | ELDN | Maintain | Buy (Buy) |
|
Details | ||
| 11/14/2024 | Dyadic International | DYAI | Maintain | Buy (Buy) |
|
Details | ||
| 11/13/2024 | Novavax | NVAX | Maintain | Buy (Buy) |
|
Details | ||
| 11/12/2024 | Can-Fite BioPharma | CANF | Maintain | Buy (Buy) |
|
Details | ||
| 10/24/2024 | Cardiol Therapeutics | CRDL | Maintain | Buy (Buy) |
|
Details | ||
| 10/8/2024 | Cassava Sciences | SAVA | Upgrade | Buy (Neutral) |
25.41 (2.38) |
-90.63% | Details | |
| 8/20/2024 | Edesa Biotech Inc. | EDSA | Maintain | Buy (Buy) |
|
Details | ||
| 8/2/2024 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2024 | Cassava Sciences | SAVA | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/9/2024 | Windtree Therapeutics | WINT | Maintain | Neutral (N/A) |
|
Details | ||
| 7/8/2024 | Dyadic International | DYAI | Maintain | Buy (Buy) |
|
Details | ||
| 7/2/2024 | GeoVax Labs Inc. | GOVX | Maintain | Buy (Buy) |
|
Details | ||
| 7/1/2024 | Cassava Sciences | SAVA | Downgrade | Neutral (Buy) |
12.35 (2.38) |
-80.73% | Details | |
| 6/28/2024 | Edesa Biotech Inc. | EDSA | Maintain | Buy (Buy) |
|
Details | ||
| 6/25/2024 | Aethlon Medical | AEMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2024 | Cassava Sciences | SAVA | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2024 | Eledon Pharamceuticals | ELDN | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2024 | Cardiol Therapeutics | CRDL | New Coverage | Buy (N/A) |
1.77 (1.05) |
-40.68% | Details | |
| 3/4/2024 | Aethlon Medical | AEMD | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2024 | Phio Pharma | PHIO | Maintain | Buy (N/A) |
|
Details | ||
| 1/30/2024 | Enveric Biosciences | ENVB | New Coverage | Buy (N/A) |
0.90 (1.32) |
46.67% | Details | |
| 1/3/2024 | Windtree Therapeutics | WINT | New Coverage | Neutral (N/A) |
0.70 (0.11) |
-84.29% | Details | |
| 12/14/2023 | Moleculin Biotech | MBRX | New Coverage | Buy (N/A) |
0.53 (0.67) |
26.42% | Details | |
| 11/29/2023 | Edesa Biotech Inc. | EDSA | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2023 | Gamida Cell Ltd. | GMDA | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2023 | Aethlon Medical | AEMD | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2023 | Eledon Pharamceuticals | ELDN | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2023 | Aridis Pharmaceuticals | ARDS | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2023 | Acer Therapeutics | ACER | Downgrade | Neutral (Buy) |
1.14 (0.90) |
-21.05% | Details | |
| 8/21/2023 | Finch Therapeutics Group Inc. | FNCH | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2023 | Edesa Biotech Inc. | EDSA | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2023 | Senseonics Holdings | SENS | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2023 | Citius Pharmaceuticals | CTXR | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2023 | Aytu Biosciences | AYTU | Maintain | Buy (N/A) |
|
Details | ||
| 5/25/2023 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2023 | Artelo Biosciences, Inc. | ARTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2023 | Blue Water Vaccines Inc. | BWV | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2023 | Gamida Cell Ltd. | GMDA | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2023 | Finch Therapeutics Group Inc. | FNCH | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | Gamida Cell Ltd. | GMDA | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2023 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | AIkido Pharma Inc | AIKI | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2022 | GeoVax Labs Inc. | GOVX | New Coverage | Buy (N/A) |
0.87 (1.13) |
29.89% | Details | |
| 10/7/2022 | Aptorum Group Ltd. | APM | New Coverage | Buy (N/A) |
0.89 (0.81) |
-8.99% | Details | |
| 8/22/2022 | AIkido Pharma Inc | AIKI | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2022 | Senseonics Holdings | SENS | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2022 | NRx Pharmaceuticals, Inc. | NRXP | New Coverage | Buy (N/A) |
0.57 (4.09) |
617.54% | Details | |
| 5/19/2022 | TFF Parmaceuticals | TFFP | New Coverage | Buy (N/A) |
4.99 (0.07) |
-98.6% | Details | |
| 4/4/2022 | Dyadic International | DYAI | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2022 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2022 | Acer Therapeutics | ACER | New Coverage | Buy (N/A) |
2.27 (0.90) |
-60.35% | Details | |
| 12/20/2021 | Edesa Biotech Inc. | EDSA | New Coverage | Buy (N/A) |
5.71 (1.95) |
-65.85% | Details | |
| 12/17/2021 | Dyadic International | DYAI | New Coverage | Buy (N/A) |
3.87 (1.10) |
-71.58% | Details | |
| 11/1/2021 | Artelo Biosciences Inc. | ARTL | New Coverage | Buy (N/A) |
0.72 (1.02) |
41.67% | Details | |
| 10/21/2021 | Ra Medical Systems Inc. | RMED | New Coverage | Buy (N/A) |
3.00 (0.59) |
-80.33% | Details | |
| 10/13/2021 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2021 | AIkido Pharma Inc | AIKI | New Coverage | Buy (N/A) |
0.87 (3.56) |
309.2% | Details | |
| 8/19/2021 | Senseonics Holdings | SENS | New Coverage | Buy (N/A) |
3.12 (6.26) |
100.64% | Details | |
| 7/20/2021 | Cassava Sciences | SAVA | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2021 | Predictive Oncology | POAI | New Coverage | Buy (N/A) |
1.04 (0.88) |
-15.38% | Details | |
| 6/25/2021 | Aethlon Medical | AEMD | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2021 | Phio Pharma | PHIO | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2021 | Aethlon Medical | AEMD | New Coverage | Buy (N/A) |
1.74 (0.69) |
-60.34% | Details | |
| 5/12/2021 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2021 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2021 | Gamida Cell Ltd. | GMDA | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2020 | Tenax Therapeutics | TENX | New Coverage | Buy (N/A) |
1.07 (16.10) |
1404.67% | Details | |
| 10/6/2020 | miRagen Therapeutics | MGEN | Downgrade | Neutral (Buy) |
0.76 (23.01) |
2927.63% | Details | |
| 9/23/2020 | Cassava Sciences | SAVA | Upgrade | Buy (Neutral) |
10.45 (2.38) |
-77.22% | Details | |
| 8/26/2020 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2020 | Vaxart Inc. | VXRT | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | CEL-SCI | CVM | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2020 | Aytu Biosciences | AYTU | New Coverage | Buy (N/A) |
1.40 (2.23) |
59.29% | Details | |
| 5/18/2020 | Cassava Sciences | SAVA | Downgrade | Neutral (Buy) |
2.12 (2.38) |
12.26% | Details | |
| 5/14/2020 | CEL-SCI | CVM | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2020 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
0.50 (2.58) |
416% | Details | |
| 2/10/2020 | vTv Therapeutics | VTVT | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2020 | Citius Pharmaceuticals | CTXR | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2020 | CEL-SCI | CVM | New Coverage | Buy (N/A) |
7.78 (1.23) |
-84.19% | Details | |
| 11/27/2019 | Novus Therapeutics, Inc | NVUS | New Coverage | Buy (N/A) |
0.60 (14.60) |
2333.33% | Details | |
| 11/22/2019 | Navidea Biopharmaceuticals | NAVB | New Coverage | Buy (N/A) |
0.68 (0.00) |
-100% | Details | |
| 10/24/2019 | Neovasc | NVCN | New Coverage | Buy (N/A) |
3.61 (30.03) |
731.86% | Details | |
| 9/24/2019 | Can-Fite BioPharma | CANF | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2019 | Citius Pharmaceuticals | CTXR | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2019 | miRagen Therapeutics | MGEN | New Coverage | Buy (N/A) |
0.91 (23.01) |
2428.57% | Details | |
| 8/14/2019 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2019 | ENDRA Life Science | NDRA | New Coverage | Buy (N/A) |
1.43 (5.19) |
262.94% | Details | |
| 5/30/2019 | vTv Therapeutics | VTVT | New Coverage | Buy (N/A) |
1.75 (15.80) |
802.86% | Details | |
| 2/7/2019 | Citius Pharmaceuticals | CTXR | New Coverage | Buy (N/A) |
0.99 (0.70) |
-29.29% | Details | |
| 1/28/2019 | Novavax | NVAX | New Coverage | Buy (N/A) |
2.19 (8.89) |
305.94% | Details |
